Open an account

Hyperion DeFi

HYPD · NASDAQ

$2.98+$0.115 (+4.02%)TodayMarket closed ·
Prev close $2.86

About HYPD

Hyperion DeFi, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company is headquartered in New York City, New York and currently employs 9 full-time employees. The company went IPO on 2018-01-25. The firm is focused on providing simplified access to the Hyperliquid ecosystem. The company is also developing its proprietary Optejet User Filled Device (UFD) that is designed to work with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The Optejet is useful in chronic front-of-the-eye diseases due to its ease of use, enhanced safety and tolerability, and potential for superior compliance versus standard eye drops. Together, these benefits may result in higher treatment compliance and better outcomes for patients and providers. The company has launched its cryptocurrency treasury reserve, which is native to the decentralized digital asset exchange and Layer-1 blockchain, Hyperliquid. Hyperliquid is a layer one blockchain (L1) written and optimized from first principles.

Employees
9
Headquarters
New York City, New York
Listed
Jan 25, 2018
Sector
Health Care
Industry
Pharmaceuticals
Website
hyperiondefi.com

HYPD key statistics

Market cap
46.23M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
425.22K
Volume
270.21K
Open price
$2.86
High today
$3.03
Low today
$2.84
52 Week high
$9.13
52 Week low
$2.34

Hyperion DeFi (HYPD) at a glance

Hyperion DeFi (HYPD) last traded at $2.98, with a market cap of 46.23M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $2.84 and $3.03. The current price is 4.8% above the day's low and 1.8% below its high.

Volume so far is 270.21K shares, below the average of 425.22K shares a day.

Over the past year Hyperion DeFi has ranged from $2.34 to $9.13, and now sits 9% of the way up that range.

Hyperion DeFi met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $0.93 per share against an estimate of $4.80.

The average analyst price target is $10.02, 236.9% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 3 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $10.02
Low
$8.53
Now
$2.98
High
$11.76

HYPD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 49.2% on average.

  1. Q1 FY24: reported -$18.40 per share against an estimate of -$14.23
  2. Q2 FY24: reported -$16.80 per share against an estimate of -$12.24
  3. Q3 FY24: reported -$8.80 per share against an estimate of -$10.88
  4. Q4 FY24: reported -$6.93 per share against an estimate of -$7.34
  5. Q1 FY25: reported -$1.63 per share against an estimate of -$9.79
  6. Q4 FY25: reported -$7.76 per share against an estimate of -$4.71
  7. Q1 FY26: reported $0.26 per share against an estimate of $0.1377
  8. Q2 FY26: reported $0.93 per share against an estimate of $4.80

HYPD news

  • Aniket Verma

    Trump's White House Endorsement 'Extremely Positive,' Says Hyperion DeFi CEO: Executive Explains Why HYPE Ownership Is 'Beneficial'

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releasePRNewswire

    Corporate Treasury Revolution Accelerates as $113 Billion Bitcoin Holdings Spark 150% Stock Surges

  • Press releasePRNewswire

    Corporate Crypto Treasury Surge Accelerates as Bitcoin Hits Fresh Institutional Milestone

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

Similar companies

Companies in the same industry as Hyperion DeFi

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.